This site is intended for US Healthcare Professionals

 

Learn About the
CAPRELSA REMS Program

To prescribe CAPRELSA® (vandetanib) Tablets, you must enroll in the CAPRELSA REMS Program and complete the prescriber training program.

Certification in the CAPRELSA REMS Program requires 4 steps:

  1. Review CAPRELSA REMS Prescriber Training Pamphlet pdf, or CAPRELSA REMS Prescriber Training Slide Deck pdf, and the CAPRELSA Prescribing Information pdf
  2. Begin enrollment in the CAPRELSA REMS Program by filling out the demographic information in the CAPRELSA REMS Prescriber Enrollment Form online or by calling the CAPRELSA REMS Program
  3. Continue with the enrollment process by completing the CAPRELSA REMS Prescriber Training Questions online or by calling the CAPRELSA REMS Program
  4. Complete the enrollment process by reviewing and acknowledging the prescriber agreement, including acknowledgement to review the CAPRELSA Patient Brochure with the patient or caregiver online or by c ailing the CAPRELSA REMS Program. At the completion of this process the prescriber is enrolled in the REMS and is considered certified to prescribe CAPRELSA

Enroll online or call 1-800-817-2722.

Distribution of CAPRELSA

 

CAPRELSA is not available at retail pharmacies and can only be dispensed through a restricted distribution program.

 

Please see the Prescribing Information for CAPRELSA, including boxed WARNING. pdf

 

Only certified prescribers can prescribe CAPRELSA.

Enroll in the CAPRELSA REMS Program to become certified to prescribe.


You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.


CAPRELSA is a registered trademark of Genzyme Corporation.